ARMP

ArmataF

NYSE American / Pharmaceuticals, Biotechnology & Life Sciences

At close

2026-07-18

View Chart

Current thesis

Composite grade F from latest DB weights. Momentum 0.0 / Value 41.1

Posture

Defensive

Lead driver

Value

What changed

Value remains the lead driver in the composite, 7D delta -0.1.

What can break

Mixed signals. Wait for cleaner trend confirmation.

Momentum

Value

Sentiment

N/A

Setup hits (3d)

0 · Net Neutral

AI TargetsBase - · Bull - · Bear -

Data freshness

Prices

As of 2026-07-18

Fundamentals

As of 2026-07-17 • Vendor: Data Vendor v1

Scores

As of 2026-07-18 • Model: HYBRID_IC_RP

AI Memo

Unavailable: No memo yet

Investment thesis

As of 2026-07-18

Supporting evidence

What

Grade F · Defensive

Confidence Medium · Net Neutral

Target $17.50

Why

Momentum0 · Δ7d -

Value41 · Δ7d -0.1

SentimentN/A · Δ7d -

So what

Weak posture (Net Neutral). Prioritize risk control and patience.

Lead driver: Value · See fundamentals

Momentum

40% active weight

Current posture

7d trendTrend unavailable

Trend unavailable

Δ7d

Δ21d

Value

60% active weight

Current posture

7d trendFlat

Δ7d

-0.1

Δ21d

Sentiment

N/A

Coverage pending

No current score

7d trendTrend unavailable

Trend unavailable

Δ7d

Δ21d

Why this grade

Composite grade F. Momentum 0.0 / Value 41.1

Fundamentals (TTM)

As of 2026-07-17

Market Cap

$165.57M

Beta

1.43

Shares Out

36.71M

P/E (TTM) · Derived

-0.9

P/S (TTM)

45.74

P/FCF (TTM) · Derived

-6.69

Rev YoY

+60.7%

EPS YoY

+1649.3%

Gross Margin

+69.0%

Op Margin

-617.0%

Net Debt

$279.33M

Current Ratio

0.64

As of 2026-07-18 • Updated nightlySource: Internal modelMethodology